Ceres Acquisition Ret. on equity
What is the Ret. on equity of Ceres Acquisition?
The Ret. on equity of Ceres Acquisition Corp. is -102.54%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Finance sector on OTC compared to Ceres Acquisition
What does Ceres Acquisition do?
Ceres Acquisition Corp. does not have significant operations. It focuses on identifying and evaluating opportunities for the acquisition of assets or business with a view to completing a qualifying transaction. The company intends to identify business opportunities in the field of the cannabis industry. Ceres Acquisition Corp. was incorporated in 2020 and is headquartered in Los Angeles, California.
Companies with ret. on equity similar to Ceres Acquisition
- NeuroVive Pharmaceutical AB has Ret. on equity of -102.71%
- ECMOHO Ltd has Ret. on equity of -102.70%
- Total Brain has Ret. on equity of -102.69%
- Alector has Ret. on equity of -102.63%
- Unique Fabricating Inc has Ret. on equity of -102.60%
- The Fertilisers And Chemicals Travancore has Ret. on equity of -102.60%
- Ceres Acquisition has Ret. on equity of -102.54%
- Dacian Gold has Ret. on equity of -102.54%
- Atomera Inc has Ret. on equity of -102.30%
- SkinBioTherapeutics Plc has Ret. on equity of -102.27%
- Payright has Ret. on equity of -102.25%
- Sensorion SAS has Ret. on equity of -102.25%
- ReTo Eco-Solutions Inc has Ret. on equity of -102.22%